Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | MAOB | P27338 | 5/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | AR | P10275 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.34 |
| ▸ | DRD1 | P21728 | 3/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9587789 | 0.80 | TSHR (0.41) | TSHRMAOBSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL19057694 | 0.79 | TSHR (0.39) | TSHRMAOBSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL1472469 | 0.70 | CYP2C19 (0.33) | TSHRMAOBSLC6A2SLC6A3CYP2C19 | |
| SCHEMBL21858942 | 0.70 | SLC6A2 (0.41) | SLC6A2SLC6A4SLC6A3DRD1 | |
| SCHEMBL17937271 | 0.69 | CYP2D6 (0.34) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL17937255 | 0.69 | CYP2D6 (0.34) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL20483742 | 0.69 | CYP2D6 (0.34) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL17937249 | 0.69 | CYP2D6 (0.34) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL17937245 | 0.69 | CYP2D6 (0.34) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL17937258 | 0.69 | CYP2D6 (0.34) | CHRM2CHRM4CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110099993-B | High impact perfume microcapsules of balanced density | 弗门尼舍有限公司 | 2021-08-24 | — | — | CN | claimed |
| US-10918579-B2 | Density balanced high impact perfume microcapsules | FIRMENICH SA (CH) | 2021-02-16 | — | — | US | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| CN-102578133-A | Spray for controlling sanitary insect pests | ZHONGSHAN LANJU DAILY CHEM IND CO LTD | 2012-07-18 | — | — | CN | claimed |
| EP-2129758-A2 | PERFUME COMPOSITIONS | Givaudan Nederland Services B.V. (NL) | 2009-12-09 | — | — | EP | claimed |
| WO-2008104352-A2 | PERFUME COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2008-09-04 | — | — | WO | claimed |
| CN-1361817-A | Perfume compositions | PROCTER & GAMBLE (US) | 2002-07-31 | — | — | CN | claimed |
| EP-1072673-A2 | Perfume compositions | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-31 | — | — | EP | claimed |
| WO-2001005919-A2 | PERFUME COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-25 | — | — | WO | claimed |
| CN-122028974-A | Ribonucleic acid-based microcapsules | 弗门尼舍有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20250332075-A1 | POLYAMIDE MICROCAPSULES | FIRMENICH & CIE (CH) | 2025-10-30 | — | — | US | disclosed |
| CN-120091807-A | Lipid-based microcapsules | 弗门尼舍有限公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-120076721-A | Wax-based microcapsules | 弗门尼舍有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-119923291-A | Mixed microcapsules | 弗门尼舍有限公司 | 2025-05-02 | — | — | CN | disclosed |
| US-5907048-A | REACTING AN ALDEHYDE WITH CONJUGATED DIENE IN PRESENCE OF LEWIS ACID CATALYST AND A CO-CATALYST SELECTED FROM A BASE AND A COMPOUND SUCH AS AN ESTER, CHLORO-ACETIC ESTER, ETHER, KETONE, CARBONATE, CAPABLE OF DISSOLVING LEWIS ACID | KAO CORPORATION (JP) | 1999-05-25 | — | — | US | disclosed |
| CN-1180701-A | Process for preparing dihydropyrane compound | KAO CORP (JP) | 1998-05-06 | — | — | CN | disclosed |
| EP-0834509-A1 | Process for preparing dihydropyrane compound | Kao Corporation (JP) | 1998-04-08 | — | — | EP | disclosed |
| US-5162551-A | PROCESS FOR THE PREPARATION OF DIHYDROPYRANS | NAARDEN INTERNATIONAL, N.V. (NL) | 1992-11-10 | — | — | US | disclosed |
| EP-0325000-B1 | PROCESS FOR THE PREPARATION OF DIHYDROPYRANS | NAARDEN INTERNATIONAL N.V. (NL) | 1992-05-13 | — | — | EP | disclosed |
| EP-0325000-A1 | Process for the preparation of dihydropyrans | NAARDEN INTERNATIONAL N.V. (NL) | 1989-07-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250332075-A1 | POLYAMIDE MICROCAPSULES | PSAP, POLI, PGA5 | TSHR 3726/4885MAOB 514/4885SLC6A2 4791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.